biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD No No

<< Previous

Bullboard Posts

Next >>

Comment by Itistooon Dec 21, 2021 2:53pm

171 Views

Post# 34251676

RE:RE:RE:RE:RE:RE:RE:RE:JD No No

no kidding, jd sure gets a tough time on these boards. He's about the only person I've seen post useful info about the company and just gets lambasted for it. Biotech stocks especially small caps are highly risky and more likely to not pan out. So either shut up and sell or shut up and wait

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec